KGA-2727
CAS:
Ref. 3D-RBB84236
Información del producto
Nombre:KGA-2727
Marca:Biosynth
Descripción:KGA-2727 is a novel, orally administered, non-peptidic, small molecule antidiabetic agent that increases glucose uptake in skeletal muscle cells by inhibiting the sodium-dependent glucose transporter type 2 (SGLT2) and the accompanying sodium-glucose cotransporter. KGA-2727 has been shown to lower blood pressure and increase insulin sensitivity in diabetic mice. Chronic treatment with KGA-2727 has been shown to increase insulin sensitivity in wild-type mice without any adverse effects. This drug also lowers blood sugar levels in patients with type 2 diabetes.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:536.6 g/mol
Fórmula:C26H40N4O8
Pureza:Min. 95%